Renaissance Technologies
CADX

Renaissance Technologies’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Renaissance Technologies’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-54,300
Closed -$491K – 3220
2013
Q4 		$491K Buy
+54,300
New +$392K ﹤0.01% 2358

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies's CADX Position: Q1 2014 in Review

Renaissance Technologies sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 54,300 shares — an estimated $491K sold.

Renaissance Technologies first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $491K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Renaissance Technologies reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Renaissance Technologies sold 54,300 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $491K.
  • Renaissance Technologies first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • Renaissance Technologies's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $491K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Renaissance Technologies's 13F filing for Q1 2014, filed 14 May 2014.